Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 216
Selected: 0
NCT IDTitle
NCT06027307Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
NCT04613895Treatment Effect According to Timing of Administration of DWP14012 40 mg
NCT05376969Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
NCT06109259Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
NCT04782505Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers
NCT02757144Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
NCT00845819Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies
NCT02882893Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines
NCT03485534Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients
NCT06751121Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
NCT03009487A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
NCT02089399Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers
NCT06062030Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;
NCT03487562Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
NCT06437951to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
NCT02415777Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction
NCT05378360DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
NCT05072938Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
NCT02180334The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones
NCT04341454Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
NCT04328766Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers
NCT02369302Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers
NCT04535856Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients
NCT01964365Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers
NCT05797922To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers
NCT01397240The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients
NCT05614778Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis
NCT05832697An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers
NCT04221399Type 2 Diabetes Patients With Renal Impairment
NCT01636401Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT05813561The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
NCT02385032Comparative Bioavailability Study of UDCA
NCT06668506To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
NCT06419816Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
NCT04634500The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
NCT01094834A Multiple Dose Study of DWP05195 in Healthy Adult Subjects
NCT02568150Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines
NCT03512808A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions
NCT01713920Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
NCT05614752Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
NCT06212960Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT02044250Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
NCT03184363Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)
NCT04827472Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers
NCT05414591Pharmacokinetics and Safety Following Administration of DWP16001
NCT03846453A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03946592Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat
NCT03517319Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
NCT05816681Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
NCT04721535A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2